Several start-ups in the targeted delivery field had announcements to make this week. Aradigm, which is developing an inhaler for delivery of small-molecule drugs and biologics, succeeded in raising $4.1 million in...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)